Clinical Trial Update: Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for Angiotensin-(1,7) treatment in COVID-19 (ATCO Trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Respiratory Failure

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Erasme University Hospital | Conditions: Coronavirus, Respiratory Failure | Phase 2, Phase 3 | Status: UNKNOWN